Antitumor/Antifungal Celecoxib Derivative AR-12 is a Non-Nucleoside Inhibitor of the ANL-Family Adenylating Enzyme Acetyl CoA Synthetase

[Image: see text] AR-12/OSU-03012 is an antitumor celecoxib-derivative that has progressed to Phase I clinical trial as an anticancer agent and has activity against a number of infectious agents including fungi, bacteria and viruses. However, the mechanism of these activities has remained unclear. B...

Descripción completa

Detalles Bibliográficos
Autores principales: Koselny, Kristy, Green, Julianne, Favazzo, Lacey, Glazier, Virginia E., DiDone, Louis, Ransford, Shea, Krysan, Damian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2016
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828684/
https://www.ncbi.nlm.nih.gov/pubmed/27088128
http://dx.doi.org/10.1021/acsinfecdis.5b00134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828684/
https://www.ncbi.nlm.nih.gov/pubmed/27088128
http://dx.doi.org/10.1021/acsinfecdis.5b00134

Ejemplares similares